Cargando…

Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report

BACKGROUND: Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function. However, little research has been published on the impact of the immunomodulatory effect of (hydroxy)chloroquine on humoral immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muyldermans, Astrid, Maes, Piet, Wawina-Bokalanga, Tony, Anthierens, Tine, Goldberg, Olivier, Bartiaux, Magali, Soetens, Oriane, Wybo, Ingrid, Van den Wijngaert, Sigi, Piérard, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620303/ https://www.ncbi.nlm.nih.gov/pubmed/34836543 http://dx.doi.org/10.1186/s13256-021-03159-9

Ejemplares similares

Healthcare-Associated SARS-CoV-2 Reinfection after 3 Months with a Phylogenetically Distinct Omicron Variant: A Case Report
por: Callebaut, Kim, et al.
Publicado: (2022)

SARS-CoV-2 RNA and antibodies in tear fluid
por: Muyldermans, Astrid, et al.
Publicado: (2021)

Culturomics to Investigate the Endometrial Microbiome: Proof-of-Concept
por: Vanstokstraeten, Robin, et al.
Publicado: (2022)

Validation of Rapid Antimicrobial Susceptibility Testing directly from blood cultures using WASPLab(®), including Colibrí(™) and Radian(®) in-Line Carousel
por: Herroelen, Pauline Hilda, et al.
Publicado: (2022)

Improving specificity of Bordetella pertussis detection using a four target real-time PCR
por: Martini, Helena, et al.
Publicado: (2017)

Complete Genome Sequence of a New Ebola Virus Strain Isolated during the 2017 Likati Outbreak in the Democratic Republic of the Congo
por: Wawina-Bokalanga, Tony, et al.
Publicado: (2019)

Toxigenic Corynebacterium ulcerans in human and non-toxigenic Corynebacterium diphtheriae in cat
por: Detemmerman, L, et al.
Publicado: (2013)

Validation of the Colibrí Instrument for Automated Preparation of MALDI-TOF MS Targets for Yeast Identification
por: Heestermans, Robbe, et al.
Publicado: (2022)

Genomic evidence of co-identification with Omicron and Delta SARS-CoV-2 variants: a report of two cases
por: Wawina-Bokalanga, Tony, et al.
Publicado: (2022)

Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria
por: Wybo, Ingrid, et al.
Publicado: (2014)

Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe
por: Vanmechelen, Bert, et al.
Publicado: (2022)

Design and validation of a laboratory-developed diagnostic assay for monkeypox virus
por: Sklenovská, Nikola, et al.
Publicado: (2023)

In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis
por: De Schutter, Iris, et al.
Publicado: (2012)

Healthcare-Associated COVID-19 across Five Pandemic Waves: Prediction Models and Genomic Analyses
por: Demuyser, Thomas, et al.
Publicado: (2022)

Comparing Vaginal and Endometrial Microbiota Using Culturomics: Proof of Concept
por: Vanstokstraeten, Robin, et al.
Publicado: (2023)

Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates
por: Vanstokstraeten, R., et al.
Publicado: (2023)

Symptomatic reinfection with COVID-19: A first from Western India
por: Vora, Tanisha, et al.
Publicado: (2021)

Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection
por: Murillo-Zamora, E., et al.
Publicado: (2021)

Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua
por: Kubale, John, et al.
Publicado: (2022)

Symptomatic malaria enhances protection from reinfection with homologous Plasmodium falciparum parasites
por: Markwalter, Christine F., et al.
Publicado: (2023)

Symptomatic malaria enhances protection from reinfection with homologous Plasmodium falciparum parasites
por: Markwalter, Christine F., et al.
Publicado: (2023)

Ocular surface manifestations and SARS-CoV-2 RNA detection in conjunctival swabs of patients hospitalized for COVID-19 pneumonia
por: Valyi, Zsuzsanna, et al.
Publicado: (2023)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019
por: Estabrook, Mark, et al.
Publicado: (2023)

Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics
por: Vrancken, Bram, et al.
Publicado: (2020)

Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

Zebra bodies in lupus nephritis after hydroxychloroquine therapy
por: Singh, Anshima, et al.
Publicado: (2023)

Symptomatic Reinfection in Previously Recovered Coronavirus Disease 2019 (COVID-19) Geriatric Patient
por: Jadeja, Dhigishaba, et al.
Publicado: (2021)

Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk
por: Murillo-Zamora, Efrén, et al.
Publicado: (2021)

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
por: Hanrath, Aidan T., et al.
Publicado: (2020)

SARS-CoV-2 symptomatic reinfection among patients with primary antibody deficiency
por: Marcus, Nufar, et al.
Publicado: (2022)

Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020
por: Bollen, Nena, et al.
Publicado: (2021)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
por: Piñero, David P., et al.
Publicado: (2017)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
por: Aouhab, Z., et al.
Publicado: (2019)

Hydroxychloroquine blood levels predict clotting risk in patients with lupus
Publicado: (2021)

Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States
por: Ando, Wataru, et al.
Publicado: (2022)

Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus
por: Hammami, Sonia, et al.
Publicado: (2014)

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study
por: Ip, Andrew, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bkrljq868e0pi26rb20detnd42